Ada Lovelace Centre
The Ada Lovelace Centre (ALC) is a multi-disciplinary centre of expertise in research, software engineering and data management, enhancing the scientific impact of STFC’s large-scale national facilities.
The ALC uses integrated approaches to address and solve scientific data challenges by:
- Improving how data is handled and processed within STFC facilities to extract greater scientific value and enhance understanding
- Coordinating activities across facilities to exploit cross-cutting opportunities in scientific computing
- Building and maintaining software and data infrastructure capabilities for facilities
- Forming a critical mass of staff and skills aligned to the scientific data challenges of the large facilities
- Supporting research and development activities in software engineering, data management, computational and AI methods and simulation
ALC represents an exciting opportunity to help further expand links to and across the STFC national facilities, drive new research and development to meet emerging needs, and ultimately make a significant and transformative impact on the broad range of science at the facilities.
Dr Paul Quinn, Director, Ada Lovelace Centre
News spotlight
Catering to the bespoke data analysis needs of scientific facilities using the Ada platform
Catering to the bespoke data analysis needs of scientific facilities using the Ada platform
As scientific experiments have grown larger and more complicated, so has the kind of data that they generate, and the need to store and manage this data has become increasingly more complex. The DAaaS (Data Analysis as a Service) team is tackling this issue through its new ‘Ada’ platform. For more information, please click the link below.
Related Case Studies
Catering to the bespoke data analysis needs of scientific facilities using the Ada platform
Computational software saves time, energy and costs for research experiments
Enabling Remote Data Analysis During the COVID Pandemic and Beyond
Machine learning tool to understand living cells and identify new drug treatments for diseases
